Aethlon readies U.S. study of the Hemopurifier

See on Scoop.it21st Century Integrative Medicine

Aethlon Medical (OTCQB:AEMD), sporting FDA approval of an investigational drug exemption (IDE), plans to begin treating patients infected with hepatitis C virus (HCV) early next year in a feasibili…

Asher Laub‘s insight:

The Hemopurifier gives more than just hope to those infected w/ viruses as pathogenic as HIV and polio and even cancer with a drug free treatment; worth noting that it is actually used in conjunction with drug therapy for a statistical high success rate.

See on biotuesdays.com

Advertisements

About davidlandau

David Landau is a graduate of NYU Steinhardt and a science educator since 2007. His interests and booking musical entertainment. His favorite musical performers are Asher www.asherlaub.com and Lindsey Stirling www.lindseystirling.com

Posted on October 22, 2013, in Uncategorized. Bookmark the permalink. Leave a comment.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: